The role of platelet activation in determining response to therapy in patients with primary nephrotic syndrome

References

• Orth SR, Ritz E. The nephrotic syndrome. N Engl J Med 1998; 338(17)1202–1211
   PubMed Web of Science ®Google Scholar
• Tune BM, Mendoza SA. Treatment of the idiopathic nephrotic syndrome: Regimens and outcomes in children and adults. J Am Soc Nephrol 1997; 8(5)824–832
   PubMed Web of Science ®Google Scholar
• Van den Berg JG, Weening JJ. Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome. Clin Sci (Lond) 2004; 107(2)125–136
   PubMed Web of Science ®Google Scholar
• Morita Y, Ikeguchi H, Nakamura J, Hotta N, Yuzawa Y, Matsuo S. Complement activation products in the urine from proteinuric patients. J Am Soc Nephrol 2000; 11(4)700–707
   PubMed Web of Science ®Google Scholar
• Rodríguez-Iturbe B, Herrera-Acosta J, Johnson RJ. Interstitial inflammation, sodium retention, and the pathogenesis of nephrotic edema: A unifying hypothesis. Kidney Int 2002; 62(4)1379–1384
   PubMed Web of Science ®Google Scholar
• McCarthy ET, Sharma M, Savin VJ. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2010; 5(11)2115–2121
   PubMed Web of Science ®Google Scholar
• Schwarz A. New aspects of the treatment of nephrotic syndrome. J Am Soc Nephrol 2001; 12(17)S44–S47
   Google Scholar
• Semple JW, Freedman J. Platelets and innate immunity. Cell Mol Life Sci 2010; 67(4)499–511
   PubMed Web of Science ®Google Scholar
• Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115: 3378–3384
   PubMed Web of Science ®Google Scholar
• Barnes JL, Hevey KA, Hastings RR, Bocanegra RA. Mesangial cell migration precedes proliferation in Habu snake venom-induced glomerular injury. Lab Invest 1994; 70(4)460–467
   PubMed Web of Science ®Google Scholar
• Barnes JL. Platelets in glomerular disease. Nephron 1997; 77(4)378–393
   PubMed Web of Science ®Google Scholar
• Martin JF, Trowbridge EA, Salmon G, Plumb J. The biological significance of platelet volume: Its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 1983; 32(5)443–460
   PubMed Web of Science ®Google Scholar
• Bath PM, Butterworth RJ. Platelet size: Measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996; 7(2)157–161
   PubMed Web of Science ®Google Scholar
• Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: A link between thrombosis and inflammation?. Curr Pharm Des. 2011; 17(1)47–58
   PubMed Web of Science ®Google Scholar
• Yazici S, Yazici M, Erer B, Erer B, Calik Y, Ozhan H, Ataoglu S. The platelet indices in patients with rheumatoid arthritis: Mean platelet volume reflects disease activity. Platelets 2010; 21(2)122–125
   PubMed Web of Science ®Google Scholar
• Confino-Cohen R, Chodick G, Shalev V, Leshno M, Kimhi O, Goldberg A, Chronic urticaria and autoimmunity: Associations found in a large population study. J Allergy Clin Immunol 2012 May;129(5):1307–13
   Google Scholar
• Sharpe PC, Trinick T. Mean platelet volume in diabetes mellitus. Q J Med 1993; 86(11)739–742
   PubMedGoogle Scholar
• Kaya MG, Yarlioglues M, Gunebakmaz O, Gunturk E, Inanc T, Dogan A, Kalay N, Topsakal R. Platelet activation and inflammatory response in patients with non-dipper hypertension. Atherosclerosis 2010; 209(1)278–282
   PubMed Web of Science ®Google Scholar
• Brown AS, Hong Y, de Belder A, Beacon H, Beeso J, Sherwood R, Edmonds M, Martin JF, Erusalimsky JD. Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis. Arterioscler Thromb Vasc Biol. 1997; 17(4)802–807
   PubMed Web of Science ®Google Scholar
• Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, Mohler ER, Reilly MP, Berger JS. Mean platelet volume as a predictor of cardiovascular risk: A systematic review and meta-analysis. J Thromb Haemost. 2010; 8(1)148–156
   PubMed Web of Science ®Google Scholar
• Zdrojewski Z, Lizakowski S, Raszeja-Specht A, Skibowska A, Rutkowski B. Influence of spontaneous platelet aggregation on progression of glomerular disease. Nephron 2002; 92(1)36–42
   PubMed Web of Science ®Google Scholar
• Wasilewska AM, Zoch-Zwierz WM, Tomaszewska B, Biernacka A. Platelet-derived growth factor and platelet profiles in childhood nephrotic syndrome. Pediatr Nephrol 2005; 20(1)36–41
   PubMed Web of Science ®Google Scholar
• Hallan S, Asberg A, Lindberg M, Johnsen H. Validation of the Modification of Diet in Renal Disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay. Am J Kidney Dis. 2004; 44(1)84–93
   PubMed Web of Science ®Google Scholar
• Bazzi C, Petrini C, Rizza V, Arrigo G, Napodano P, Paparella M, D'Amico G. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Nephrol Dial Transplant 2002; 17(11)1890–1896
   PubMed Web of Science ®Google Scholar
• Ritz E. Pathogenesis of “idiopathic” nephrotic syndrome. N Engl J Med 1994; 330(1)61–62
   PubMed Web of Science ®Google Scholar
• Zhang G, Li Q, Wang L, Chen Y, Zhang W, Yang H. The effects of inflammation on lipid accumulation in the kidneys of children with primary nephrotic syndrome. Inflammation. 2011; 34(6)645–652
   PubMed Web of Science ®Google Scholar
• Sellier-Leclerc AL, Duval A, Riveron S, Macher MA, Deschenes G, Loirat C, Verpont MC, Peuchmaur M, Ronco P, Monteiro RC, et al. A humanized mouse model of idiopathic nephrotic syndrome suggests a pathogenic role for immature cells. J Am Soc Nephrol 2007; 18(10)2732–2739
   PubMed Web of Science ®Google Scholar
• Kausman JY, Kitching AR. A new approach to idiopathic nephrotic syndrome. J Am Soc Nephrol. 2007; 18(10)2621–2622
   PubMed Web of Science ®Google Scholar
• Shalhoub RJ. Pathogenesis of lipoid nephrosis: A disorder of T-cell function. Lancet 1974; 2(7880)556–560
   PubMed Web of Science ®Google Scholar
• Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996; 334(14)878–883
   PubMed Web of Science ®Google Scholar
• Artero ML, Sharma R, Savin VJ, Vincenti F. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 1994; 23(4)574–581
   PubMed Web of Science ®Google Scholar
• Wagner DD, Burger PC. Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol 2003; 23(12)2131–2137
   PubMed Web of Science ®Google Scholar
• Davì G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med. 2007; 13(24)2482–2494
   Google Scholar
• Camici M. The Nephrotic syndrome is an immunoinflammatory disorder. Med Hypotheses. 2007; 68(4)900–905
   PubMed Web of Science ®Google Scholar
• Elzey BD, Sprague DL, Ratliff TL. The emerging role of platelets in adaptive immunity. Cell Immunol 2005; 238(1)1–9
   PubMed Web of Science ®Google Scholar
• Sowa JM, Crist SA, Ratliff TL, Elzey BD. Platelet influence on T- and B-cell responses. Arch Immunol Ther Exp 2009; 57(4)235–241
   PubMed Web of Science ®Google Scholar
• Peerschke EI, Yin W, Ghebrehiwet B. Platelet mediated complement activation. Adv Exp Med Biol. 2008; 632: 81–91
   PubMed Web of Science ®Google Scholar
• Peters H, Border WA, Noble NA. Transforming growth factor-ß in human glomerular injury. Curr Opin Nephrol Hypertens 1997; 6: 389–393
   PubMed Web of Science ®Google Scholar
• Taraboletti G, Morigi M, Figliuzzi M, Giavazzi R, Zoja C, Remuzzi G. Thrombospondin induces glomerular mesangial cell adhesion and migration. Lab Invest 1992; 67: 566–571
   PubMed Web of Science ®Google Scholar
• Barnes JL, Camussi G, Tetta C. Glomerular localization of platelet cationic proteins after immune complex-induced platelet activation. Lab Invest 1990; 63: 755–761
   PubMed Web of Science ®Google Scholar
• Dastjerdi MS, Emami T, Najafian A, Amini M. Mean platelet volume measurement, EDTA or citrate?. Hematology 2006; 11: 317–319
   PubMed Web of Science ®Google Scholar
• Macey M, Azam U, McCarthy D, Webb L, Chapman ES, Okrongly D, Zelmanovic D, Newland A. Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology system. Clin Chem 2002; 48: 891–899
   PubMed Web of Science ®Google Scholar